Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort
Open accessThe DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Epilepsy is common in early childhood. In this age group it is associated with high rates of therapy-resistance, and with cognitive, motor, and behavioural comorbidity. A large number of genes, with wide ranging functions, are implicated in its aetiology, especially in those with therapy-resistant seizures. Identifying the more common single-gene epilepsies will aid in targeting resources, the prioritization of diagnostic testing and development of precision therapy. Previous studies of genetic testing in epilepsy have not been prospective and population-based. Therefore, the population-incidence of common genetic epilepsies remains unknown. The objective of this study was to describe the incidence and phenotypic spectrum of the most common single-gene epilepsies in young children, and to calculate what proportion are amenable to precision therapy. This was a prospective national epidemiological cohort study. All children presenting with epilepsy before 36 months of age were eligible. Children presenting with recurrent prolonged (>10 min) febrile seizures; febrile or afebrile status epilepticus (>30 min); or with clusters of two or more febrile or afebrile seizures within a 24-h period were also eligible. Participants were recruited from all 20 regional paediatric departments and four tertiary children’s hospitals in Scotland over a 3-year period. DNA samples were tested on a custom-designed 104-gene epilepsy panel. Detailed clinical information was systematically gathered at initial presentation and during follow-up. Clinical and genetic data were reviewed by a multidisciplinary team of clinicians and genetic scientists. The pathogenic significance of the genetic variants was assessed in accordance with the guidelines of UK Association of Clinical Genetic Science (ACGS). Of the 343 patients who met inclusion criteria, 333 completed genetic testing, and 80/333 (24%) had a diagnostic genetic finding. The overall estimated annual incidence of single-gene epilepsies in this well-defined population was 1 per 2120 live births (47.2/100 000; 95% confidence interval 36.9–57.5). PRRT2 was the most common single-gene epilepsy with an incidence of 1 per 9970 live births (10.0/100 000; 95% confidence interval 5.26–14.8) followed by SCN1A: 1 per 12 200 (8.26/100 000; 95% confidence interval 3.93–12.6); KCNQ2: 1 per 17 000 (5.89/100 000; 95% confidence interval 2.24–9.56) and SLC2A1: 1 per 24 300 (4.13/100 000; 95% confidence interval 1.07–7.19). Presentation before the age of 6 months, and presentation with afebrile focal seizures were significantly associated with genetic diagnosis. Single-gene disorders accounted for a quarter of the seizure disorders in this cohort. Genetic testing is recommended to identify children who may benefit from precision treatment and should be mainstream practice in early childhood onset epilepsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss-of-function (LOF) missense or truncating variants cause Dravet syndrome, the prototypic DEE 13,27 , and also the non-DEE syndrome of Genetic Epilepsy with Febrile Seizures Plus (GEFS+) 28 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The incidence of syndromes associated with de novo genetic variants is likely to be similar around the world 13 ; whereas, recessive causes occur more frequently in populations with high rates of consanguinity 14 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., et al. (2017) · Epilepsia · doi:10.1111/epi.13709 · Cited by 5,054 · cited 1×
“The concept of the ‘developmental and epileptic encephalopathy’ (DEE) recognizes that in children presenting with early-onset epilepsy, neurodevelopmental comorbidity may be attributable to both the underlying cause and to the detrimental effects of uncontrolled epileptic activity (Scheffer et al., 2017).”
Self-citationIncidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935–1984
Hauser, W. A., Annegers, J. F., & Kurland, L. T. (1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb02586.x · Cited by 2,073
Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies
Fiest, K. M., Sauro, K. M., Wiebe, S., Patten, S. B., Kwon, C.-S., Dykeman, J., Pringsheim, T., Lorenzetti, D. L., & Jetté, N. (2017) · Neurology · doi:10.1212/wnl.0000000000003509 · Cited by 1,902
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611618 · Cited by 1,711
Estimation of the burden of active and life-time epilepsy: a meta-analytic approach
Ngugi, A. K., Bottomley, C., Kleinschmidt, I., Sander, J. W., & Newton, C. R. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02481.x · Cited by 1,447 · cited 1×
“, 2017) and that 50–65 million individuals are affected worldwide (Ngugi et al., 2010; Fiest et al., 2017).”
A Potassium Channel Mutation in Neonatal Human Epilepsy
Biervert, C., Schroeder, B. C., Kubisch, C., Berkovic, S. F., Propping, P., Jentsch, T. J., & Steinlein, O. K. (1998) · Science · doi:10.1126/science.279.5349.403 · Cited by 1,073 · cited 1×
“The literature describes two distinct phenotypes associated with KCNQ2 variants: a self-limited familial neonatal seizure phenotype (Biervert et al., 1998; Singh et al., 2003) and a severe neonatal-onset developmental and epileptic encephalopathy (Weckhuysen et al.”
Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
Devinsky, O., Patel, A. D., Cross, J. H., Villanueva, V., Wirrell, E. C., Privitera, M., Greenwood, S. M., Roberts, C., Checketts, D., VanLandingham, K. E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714631 · Cited by 1,015 · cited 2×
“Cannabidiol also has efficacy in Lennox Gastaut syndrome (French et al., 2017; Devinsky et al., 2018), an epilepsy with varied aetiologies.”
Self-citationDevinsky, O., Cilio, M. R., Cross, H., Fernandez‐Ruiz, J., French, J., Hill, C., Katz, R., Di Marzo, V., Jutras‐Aswad, D., Notcutt, W. G., et al. (2014) · Epilepsia · doi:10.1111/epi.12631 · Cited by 1,000 · cited 1×
“In Dravet syndrome cannabidiol demonstrates efficacy (Devinsky et al. , 2017); however, there is no biological reason why cannabidiol should be specifically effective in this condition because it does not appear to act on sodium channels or GABA receptors (Devinsky et al. , 2014).”
Research works printed but not linked: 1
- The Broad Institute: Cambridge MA 2018. gnomAD Browser. http://gnomad.broadinstitute.org/(April 2018, date last accessed).
Cited by
Zuberi, S. M., Wirrell, E., Yozawitz, E., Wilmshurst, J. M., Specchio, N., Riney, K., Pressler, R., Auvin, S., Samia, P., Hirsch, E., et al. (2022) · Epilepsia · doi:10.1111/epi.17239 · Cited by 934
Self-citationKlepper, J., Akman, C., Armeno, M., Auvin, S., Cervenka, M., Cross, H. J., De Giorgis, V., Della Marina, A., Engelstad, K., Heussinger, N., et al. (2020) · Epilepsia Open · doi:10.1002/epi4.12414 · Cited by 285
Self-citationMiller, I., Scheffer, I. E., Gunning, B., Sanchez-Carpintero, R., Gil-Nagel, A., Perry, M. S., Saneto, R. P., Checketts, D., Dunayevich, E., Knappertz, V., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.0073 · Cited by 267
Early childhood epilepsies: epidemiology, classification, aetiology, and socio-economic determinants
Symonds, J. D., Elliott, K. S., Shetty, J., Armstrong, M., Brunklaus, A., Cutcutache, I., Diver, L. A., Dorris, L., Gardiner, S., Jollands, A., et al. (2021) · Brain · doi:10.1093/brain/awab162 · Cited by 269
“Since PRRT2-associated epilepsy is associated with a good outcome in nearly all cases, there is little selection pressure on this gene, and in 71% of cases in our study the variant was inherited.(17) It is possible that epilepsy-associated PRRT2 variants are more prevalent in the Scottish population than other populat…”
BackgroundMethodSelf-citationDevelopmental and epileptic encephalopathies: what we do and do not know
Specchio, N., & Curatolo, P. (2021) · Brain · doi:10.1093/brain/awaa371 · Cited by 164
Knight, E. M. P., Amin, S., Bahi-Buisson, N., Benke, T. A., Cross, J. H., Demarest, S. T., Olson, H. E., Specchio, N., Fleming, T. R., Aimetti, A. A., et al. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00077-1 · Cited by 160
Self-citationLópez-Rivera, J. A., Pérez‐Palma, E., Symonds, J. D., Lindy, A. S., McKnight, D., Leu, C., Zuberi, S. M., Brunklaus, A., Møller, R. S., & Lal, D. (2020) · Brain · doi:10.1093/brain/awaa051 · Cited by 171
Self-citationGenetic testing for the epilepsies: A systematic review
Sheidley, B. R., Malinowski, J., Bergner, A. L., Bier, L., Gloss, D. S., Mu, W., Mulhern, M. M., Partack, E. J., & Poduri, A. (2022) · Epilepsia · doi:10.1111/epi.17141 · Cited by 152
CDKL5 deficiency disorder: clinical features, diagnosis, and management
Leonard, H., Downs, J. A., Benke, T. A., Swanson, L. C., Olson, H. E., & Demarest, S. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00035-7 · Cited by 171
Epilepsy and developmental disorders: Next generation sequencing in the clinic
Symonds, J. D., & McTague, A. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2019.12.008 · Cited by 151
Self-citationSmith, L. A., Malinowski, J. R., Ceulemans, S., Peck, K., Walton, N., Sheidley, B. R., & Lippa, N. C. (2022) · Journal of Genetic Counseling · doi:10.1002/jgc4.1646 · Cited by 147
Developmental and epileptic encephalopathies
Scheffer, I. E., Zuberi, S., Mefford, H. C., Guerrini, R., & McTague, A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00546-6 · Cited by 158
Self-citationTanenhaus, A., Stowe, T., Young, A., McLaughlin, J., Aeran, R., Lin, I. W., Li, J., Hosur, R., Chen, M., Leedy, J., et al. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.037 · Cited by 124
Current practice in diagnostic genetic testing of the epilepsies
Krey, I., Platzer, K., Esterhuizen, A. I., Berkovic, S. F., Helbig, I., Hildebrand, M. S., Lerche, H., Lowenstein, D. H., Møller, R. S., Poduri, A., et al. (2022) · Epileptic Disorders · doi:10.1684/epd.2022.1448 · Cited by 127
Monogenic Epilepsies: Disease Mechanisms, Clinical Phenotypes, and Targeted Therapies
Guerrini, R., Balestrini, S., Wirrell, E. C., & Walker, M. C. (2021) · Neurology · doi:10.1212/wnl.0000000000012744 · Cited by 108
Biological concepts in human sodium channel epilepsies and their relevance in clinical practice
Brunklaus, A., Du, J., Steckler, F., Ghanty, I. I., Johannesen, K. M., Fenger, C. D., Schorge, S., Baez‐Nieto, D., Wang, H., Allen, A., et al. (2020) · Epilepsia · doi:10.1111/epi.16438 · Cited by 98
Self-citationEpilepsy Syndromes in the First Year of Life and Usefulness of Genetic Testing for Precision Therapy
Bayat, A., Bayat, M., Rubboli, G., & Møller, R. S. (2021) · Genes · doi:10.3390/genes12071051 · Cited by 98
Donnan, A. M., Schneider, A. L., Russ-Hall, S., Churilov, L., & Scheffer, I. E. (2023) · Neurology · doi:10.1212/wnl.0000000000207080 · Cited by 97
Poke, G., Stanley, J., Scheffer, I. E., & Sadleir, L. G. (2023) · Neurology · doi:10.1212/wnl.0000000000206758 · Cited by 96
“Our cumulative incidences for other DEE epilepsy syndromes with onset before the age of 3 years, such as Dravet syndrome, Ohtahara syndrome, EME, and PCDH19 clustering epilepsy, are similar to previous reports (Table).(6,8,24,26)”
ResultGuidance on Dravet syndrome from infant to adult care: Road map for treatment planning in Europe
Cardenal‐Muñoz, E., Auvin, S., Villanueva, V., Cross, J. H., Zuberi, S. M., Lagae, L. G., & Aibar, J. Á. (2021) · Epilepsia Open · doi:10.1002/epi4.12569 · Cited by 110
Self-citationMcKnight, D., Morales, A., Hatchell, K. E., Bristow, S. L., Bonkowsky, J. L., Perry, M. S., Berg, A. T., Borlot, F., Esplin, E. D., Moretz, C., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.3651 · Cited by 99
“The First Thousand Days” Define a Fetal/Neonatal Neurology Program
Scher, M. S. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.683138 · Cited by 102
Lindquist, B. E., Timbie, C. M., Voskobiynyk, Y., & Paz, J. T. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106094 · Cited by 99
Structural insights into the lipid and ligand regulation of a human neuronal KCNQ channel
Zheng, Y. Y., Liu, H., Chen, Y., Dong, S., Wang, F., Wang, S., Li, G., Shu, Y., & Xu, F. (2021) · Neuron · doi:10.1016/j.neuron.2021.10.029 · Cited by 88
D'Gama, A. M., Mulhern, S., Sheidley, B. R., Boodhoo, F., Buts, S., Chandler, N. J., Cobb, J., Curtis, M., Higginbotham, E. J., Holland, J., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00246-6 · Cited by 80
Utility of genetic testing for therapeutic decision‐making in adults with epilepsy
Johannesen, K. M., Nikanorova, N., Marjanović, D., Pavbro, A., Larsen, L. H. G., Rubboli, G., & Møller, R. S. (2020) · Epilepsia · doi:10.1111/epi.16533 · Cited by 90
Current understanding of febrile seizures and their long‐term outcomes
Mewasingh, L., Chin, R., & Scott, R. C. (2020) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14642 · Cited by 93
Development and Validation of a Prediction Model for Early Diagnosis of SCN1A -Related Epilepsies
Brunklaus, A., Pérez‐Palma, E., Ghanty, I., Ji, X., Brilstra, E. H., Ceulemans, B., Chémaly, N., Lange, I., Depienne, C., Guerrini, R., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000200028 · Cited by 85
Self-citationThe clinical, economic, and humanistic burden of Dravet syndrome – A systematic literature review
Sullivan, J. E., Deighton, A. M., Vila, M. C., Szabo, S. M., Maru, B. S., Gofshteyn, J. S., James, E. S., Rico, S., & Zuberi, S. M. (2022) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2022.108661 · Cited by 80
Self-citationNegraes, P. D., Trujillo, C. A., Yu, N., Wu, W., Yao, H., Liang, N., Lautz, J. D., Kwok, E., McClatchy, D. B., Diedrich, J. K., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01104-2 · Cited by 86
The severe epilepsy syndromes of infancy: A population‐based study
Howell, K. B., Freeman, J. L., Mackay, M. T., Fahey, M. C., Archer, J., Berkovic, S. F., Chan, E., Dabscheck, G., Eggers, S., Hayman, M., et al. (2021) · Epilepsia · doi:10.1111/epi.16810 · Cited by 72
Kaneko, K., Currin, C. B., Goff, K. M., Wengert, E. R., Somarowthu, A., Vogels, T. P., & Goldberg, E. M. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110580 · Cited by 72
“…encephalopathies, affecting approximately 1 in 15,000 individuals in the United States [Wu et al., 2015]; SCN1A is in turn the most frequently identified epilepsy gene, with pathogenic variants in SCN1A associated with an estimated 0.2% of all epilepsies [Meng et al., 2015, Symonds et al., 2019].”
BackgroundInfluentialIntellectual functioning and behavior in Dravet syndrome: A systematic review
Jansson, J. S., Hallböök, T., & Reilly, C. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.107079 · Cited by 69
The current landscape of epilepsy genetics: where are we, and where are we going?
Ruggiero, S. M., Xian, J., & Helbig, I. (2023) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001141 · Cited by 82
Epilepsy-associated SCN2A (NaV1.2) variants exhibit diverse and complex functional properties
Thompson, C. H., Potet, F., Abramova, T. V., DeKeyser, J., Ghabra, N. F., Vanoye, C. G., Millichap, J. G., & George, A. L. (2023) · The Journal of General Physiology · doi:10.1085/jgp.202313375 · Cited by 76
Scala, M., Bianchi, A., Bisulli, F., Coppola, A., Elia, M., Trivisano, M., Pruna, D., Pippucci, T., Canafoglia, L., Lattanzi, S., et al. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1713101 · Cited by 66
Vanoye, C. G., Desai, R. R., Ji, Z., Adusumilli, S., Jairam, N. P., Ghabra, N. F., Joshi, N., Fitch, E., Helbig, K. L., McKnight, D., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.156314 · Cited by 74
Scheffer, I. E., French, J. A., Valente, K. D. R., Auvin, S., Cross, J. H., & Specchio, N. (2025) · Epilepsia · doi:10.1111/epi.18265 · Cited by 72
Widespread genomic influences on phenotype in Dravet syndrome, a ‘monogenic’ condition
Martins Custodio, H., Clayton, L. M., Bellampalli, R., Pagni, S., Silvennoinen, K., Caswell, R., Genomics England Research Consortium, Ambrose, J. C., Arumugam, P., Bevers, R., et al. (2023) · Brain · doi:10.1093/brain/awad111 · Cited by 62
Self-citationRecent advances in treatment of epilepsy-related sodium channelopathies
Musto, E., Gardella, E., & Møller, R. S. (2019) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2019.12.009 · Cited by 63
Terzic, B., Davatolhagh, M. F., Ho, Y., Tang, S., Liu, Y.-T., Xia, Z., Cui, Y., Fuccillo, M. V., & Zhou, Z. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143655 · Cited by 66
Genetic therapeutic advancements for Dravet Syndrome
Chilcott, E. M., Diaz, J. F. A., Bertram, C., Berti, M., & Karda, R. (2022) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2022.108741 · Cited by 62
Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies
Hu, T., Zhang, J., Wang, J., Sha, L., Xia, Y., Ortyl, T. C., Tian, X., & Chen, L. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01975 · Cited by 59
PURA- Related Developmental and Epileptic Encephalopathy: Phenotypic and Genotypic Spectrum
Johannesen, K. M., Gardella, E., Gjerulfsen, C. E., Bayat, A., Rouhl, R. P. W., Reijnders, M., Whalen, S., Keren, B., Buratti, J., Courtin, T., et al. (2021) · Neurology Genetics · doi:10.1212/nxg.0000000000000613 · Cited by 53
“In line with this, pediatric epilepsy cohort studies have not identified PURA as one of the more common causes of epilepsy in infancy.(39) However, in a recent study from our center, we identified a pathogenic variant in PURA as the underlying cause of epilepsy in 1% of adult patients.”
ResultPalmer, E. E., Howell, K., & Scheffer, I. E. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01133-3 · Cited by 53
Aged heterozygous Cdkl5 mutant mice exhibit spontaneous epileptic spasms
Mulcahey, P. J., Tang, S., Takano, H., White, A., Portillo, D. R. D., Kane, O., Marsh, E. D., Zhou, Z., & Coulter, D. A. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113388 · Cited by 51
Brunklaus, A., & Lal, D. (2020) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14519 · Cited by 57
Self-citationExpanded clinical phenotype spectrum correlates with variant function in SCN2A-related disorders
Berg, A. T., Thompson, C. H., Myers, L. S., Anderson, E. L., Evans, L. M., Kaiser, A. J. E., Paltell, K. C., Nili, A. N., DeKeyser, J., Abramova, T. V., et al. (2024) · Brain · doi:10.1093/brain/awae125 · Cited by 60
Stödberg, T., Tomson, T., Barbaro, M., Stranneheim, H., Anderlid, B., Carlsson, S., Åmark, P., & Wedell, A. (2020) · Epilepsia · doi:10.1111/epi.16701 · Cited by 46
Seizures in Mouse Models of Rare Neurodevelopmental Disorders
Fallah, M. S., & Eubanks, J. H. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.01.041 · Cited by 50
Hernandez, C. C., Tian, X., Hu, N., Shen, W., Catron, M. A., Yang, Y., Chen, J., Jiang, Y., Zhang, Y., & Macdonald, R. L. (2021) · Brain Communications · doi:10.1093/braincomms/fcab033 · Cited by 43
Miceli, F., Millevert, C., Soldovieri, M. V., Mosca, I., Ambrosino, P., Carotenuto, L., Schrader, D. V., Lee, H. K., Riviello, J. J., Hong, W., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104130 · Cited by 48
Terzic, B., Cui, Y., Edmondson, A. C., Tang, S., Sarmiento, N., Zaitseva, D., Marsh, E. D., Coulter, D. A., & Zhou, Z. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105176 · Cited by 42
Changing Landscape of Dravet Syndrome Management: An Overview
Samanta, D. (2020) · Neuropediatrics · doi:10.1055/s-0040-1701694 · Cited by 42
Refining Genotypes and Phenotypes in KCNA2-Related Neurological Disorders
Döring, J. H., Schröter, J., Jüngling, J., Biskup, S., Klotz, K. A., Bast, T., Dietel, T., Korenke, G. C., Christoph, S., Brennenstuhl, H., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062824 · Cited by 43
Juandó‐Prats, C., James, E. S., Bilder, D. A., McNair, L. A., Kenneally, N., Helfer, J., Huang, N., Vila, M. C., Sullivan, J. E., Wirrell, E. C., et al. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.108198 · Cited by 44
Gillentine, M. A., Wang, T., & Eichler, E. E. (2022) · Biomedicines · doi:10.3390/biomedicines10112865 · Cited by 45
Jang, S. S., Kim, S. Y., Kim, H., Hwang, H. Y., Chae, J., Kim, K. J., Kim, J., & Lim, B. C. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00988 · Cited by 40
Harvey, S., King, M. D., & Gorman, K. M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.659064 · Cited by 44
Kim, S. Y., Jang, S. S., Kim, H., Hwang, H. Y., Choi, J., Chae, J., Kim, K. J., & Lim, B. C. (2021) · Clinical Genetics · doi:10.1111/cge.13903 · Cited by 40
CDKL5 deficiency disorder in males: Five new variants and review of the literature
Siri, B., Varesio, C., Freri, E., Darra, F., Gana, S., Mei, D., Porta, F., Fontana, E., Galati, G., Solazzi, R., et al. (2021) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2021.04.007 · Cited by 43
Scheffer, I. E., Hulihan, J., Messenheimer, J. A., Ali, S. S., Keenan, N. F., Griesser, J., Gutterman, D. L., Sebree, T. B., & Sadleir, L. G. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.23930 · Cited by 47
Nappi, M., Barrese, V., Carotenuto, L., Lesca, G., Labalme, A., Ville, D. M., Smol, T., Rama, M., Dieux‐Coëslier, A., Rivier-Ringenbach, C., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2116887119 · Cited by 39
Bayat, A., Fenger, C., Techlo, T. R., Højte, A. F., Nørgaard, I., Hansen, T. F., Rubboli, G., Møller, R. S., & Danish Cytogenetic Central Registry Study Group (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01264-1 · Cited by 39
Epilepsy, an orphan disorder within the neurodevelopmental family
Shankar, R., Perera, B., & Thomas, R. H. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-324660 · Cited by 37
Amin, S., Monaghan, M., Aledo‐Serrano, Á., Bahi‐Buisson, N., Chin, R., Clarke, A. J., Cross, J. H., Demarest, S., Devinsky, O., Downs, J. A., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.874695 · Cited by 38
Self-citationMitta, N., Menon, R. N., McTague, A., Radhakrishnan, A., Sundaram, S., Cherian, A., Madhavilatha, G. K., Mannan, A. U., Nampoothiri, S., & Thomas, S. V. (2020) · Epilepsy Research · doi:10.1016/j.eplepsyres.2020.106398 · Cited by 43
Specchio, N., Trivisano, M., Aronica, E., Balestrini, S., Arzimanoglou, A. A., Colasante, G., Cross, J. H., Jóźwiak, S., Wilmshurst, J. M., Vigevano, F., et al. (2024) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(24)00196-2 · Cited by 39
Developmental and epileptic encephalopathy: Personal utility of a genetic diagnosis for families
Jeffrey, J. S., LEATHEM, J. M., King, C., Mefford, H. C., Ross, K. J., & Sadleir, L. G. (2021) · Epilepsia Open · doi:10.1002/epi4.12458 · Cited by 39
Boonsimma, P., Ittiwut, C., Kamolvisit, W., Ittiwut, R., Chetruengchai, W., Phokaew, C., Srichonthong, C., Poonmaksatit, S., Desudchit, T., Suphapeetiporn, K., et al. (2022) · European Journal of Human Genetics · doi:10.1038/s41431-022-01202-x · Cited by 38
Bialer, M., Johannessen, S. I., Koepp, M. J., Levy, R. H., Perucca, E., Perucca, P., Tomson, T., & White, H. S. (2022) · Epilepsia · doi:10.1111/epi.17376 · Cited by 39
Epilepsy in Dravet Syndrome—Current and Future Therapeutic Opportunities
Gao, C., Pielas, M., Jiao, F., Mei, D., Wang, X., Kotulska, K., & Jóźwiak, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072532 · Cited by 37
Levetiracetam efficacy in PCDH19 Girls Clustering Epilepsy
Sadleir, L. G., Kolc, K. L., King, C., Mefford, H. C., Dale, R. C., Gécz, J., & Scheffer, I. E. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2019.12.020 · Cited by 33
Nishiyama, M., Yamaguchi, H., Ishida, Y., Tomioka, K., Takeda, H., Nishimura, N., Nozu, K., Mishina, H., Iijima, K., & Nagase, H. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035977 · Cited by 40
Cohen, J. M., Checketts, D., Dunayevich, E., Gunning, B. W., Hyslop, A. E., Madhavan, D., Villanueva, V., Żołnowska, M., & Zuberi, S. M. (2021) · Epilepsia · doi:10.1111/epi.16974 · Cited by 35
Self-citationPredicting functional effects of ion channel variants using new phenotypic machine learning methods
Boßelmann, C. M., Hedrich, U. B. S., Lerche, H., & Pfeifer, N. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010959 · Cited by 34
Castañeda, M. S., Baltussen, L. L., Lopes, A. T., Qiu, Y., Sirvio, L., Mihaylov, S. R., Claxton, S., Richardson, J. C., Lignani, G., & Ultanir, S. K. (2023) · Nature Communications · doi:10.1038/s41467-023-43475-w · Cited by 42
Sorg, A., von Kries, R., & Borggraefe, I. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11008-y · Cited by 42
‘Channeling’ therapeutic discovery for epileptic encephalopathy through iPSC technologies
Simkin, D., Ambrosi, C. M., Marshall, K. A., Williams, L. A., Eisenberg, J., Gharib, M., Dempsey, G. T., George, A. L., McManus, O. B., & Kiskinis, E. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.03.001 · Cited by 33
Electrophysiological biomarkers of brain function in CDKL5 deficiency disorder
Saby, J. N., Mulcahey, P. J., Zavez, A. E., Peters, S. U., Standridge, S. M., Swanson, L. C., Lieberman, D. N., Olson, H. E., Key, A. P. F., Percy, A. K., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac197 · Cited by 31
Altered synaptic connectivity in an in vitro human model of STXBP1 encephalopathy
McLeod, F., Dimtsi, A., Marshall, A. C., Lewis‐Smith, D., Thomas, R. H., Clowry, G. J., & Trevelyan, A. J. (2022) · Brain · doi:10.1093/brain/awac396 · Cited by 36
Maria, B. D., Balestrini, S., Mei, D., Melani, F., Pellacani, S., Pisano, T., Rosati, A., Scaturro, G. M., Giordano, L., Cantalupo, G., et al. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62548 · Cited by 31
Zhang, Y., Hu, X., & Zou, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1457284 · Cited by 44
Clinical spectrum and genotype-phenotype correlations in PRRT2 Italian patients
Balagura, G., Riva, A., Marchese, F., Iacomino, M., Madia, F., Giacomini, T., Mancardi, M. M., Amadori, E., Vari, M. S., Salpietro, V., et al. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2020.06.005 · Cited by 28
Precision Medicine Approaches for Infantile-Onset Developmental and Epileptic Encephalopathies
Myers, K. A., & Scheffer, I. E. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-052120-084449 · Cited by 32
Hu, C., Liu, D., Luo, T., Wang, Y., & Liu, Z. (2022) · Epileptic Disorders · doi:10.1684/epd.2021.1394 · Cited by 29
Striano, P., Auvin, S., Collins, A. R., Horváth, R., Scheffer, I. E., Tzadok, M., Miller, I., Koenig, M. K., Lacy, A., Davis, R., et al. (2022) · Epilepsia · doi:10.1111/epi.17263 · Cited by 29
Dravet syndrome in children—A population-based study
Bjurulf, B., Reilly, C. J., Sigurdsson, G. V., Thunström, S., Kolbjer, S., & Hallböök, T. (2022) · Epilepsy Research · doi:10.1016/j.eplepsyres.2022.106922 · Cited by 31
Genetic Diagnosis Impacts Medical Management for Pediatric Epilepsies
Haviland, I., Daniels, C. I., Greene, C. A., Drew, J., Love-Nichols, J. A., Swanson, L. C., Smith, L. A., Nie, D. A., Benke, T. A., Sheidley, B. R., et al. (2022) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2022.10.006 · Cited by 33
Makiello, P., Feng, T., Dunwoody, B., Steckler, F., Symonds, J., Zuberi, S. M., Dorris, L., & Brunklaus, A. (2023) · Epilepsia · doi:10.1111/epi.17531 · Cited by 26
Self-citationBuñuales, M., Garduno, A., Chillón, M., Bosch, A., González-Aparicio, M., Espelosin, M., García-Gómara, M., Rico, A. J., García‐Osta, A., Cuadrado‐Tejedor, M., et al. (2024) · Gene Therapy · doi:10.1038/s41434-024-00466-w · Cited by 32
Features Differ Between Paroxysmal Kinesigenic Dyskinesia Patients with PRRT2 and TMEM151A Variants
Chen, Y., Chen, D., Li, H., & Wu, Z. (2022) · Movement Disorders · doi:10.1002/mds.28939 · Cited by 26
Millevert, C., Weckhuysen, S., & for the ILAE Genetics Commission (2023) · Epileptic Disorders · doi:10.1002/epd2.20026 · Cited by 28
Vulturar, R., Chiş, A., Pintilie, S. R., Farcaș, I. M., Botezatu, A., Login, C., Sitar-Tăut, A., Orasan, O. H., Stan, A. D., Lazea, C., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10061249 · Cited by 27
Olson, H. E., Amin, S., Bahi‐Buisson, N., Devinsky, O., Marsh, E. D., Pestana‐Knight, E., Rajaraman, R. R., Aimetti, A. A., Rybak, E., Kong, F., et al. (2023) · Epilepsia · doi:10.1111/epi.17826 · Cited by 28
Seizures and Epilepsy in Childhood
Γώγου, Μ., & Cross, J. H. (2022) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001087 · Cited by 31
Gene Editing and Modulation: the Holy Grail for the Genetic Epilepsies?
Carpenter, J. C., & Lignani, G. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01081-y · Cited by 25
POSTRE: a tool to predict the pathological effects of human structural variants
Sánchez-Gaya, V., & Rada-Iglesias, Á. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad225 · Cited by 23
Fan, H., Yang, M., Lin, L., Chiang, K.-L., & Chen, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010031 · Cited by 31
Precision therapies for genetic epilepsies in 2025: Promises and pitfalls
Wang, S., Perucca, E., Berkovic, S. F., & Perucca, P. (2025) · Epilepsia Open · doi:10.1002/epi4.70065 · Cited by 25
Metadata
- Authors
- Symonds, J. D., Zuberi, S. M., Stewart, K., McLellan, A., O‘Regan, M., MacLeod, S., Jollands, A., Joss, S., Kirkpatrick, M., Brunklaus, A., Pilz, D. T., Shetty, J., Dorris, L., Abu-Arafeh, I., Andrew, J., Brink, P., Callaghan, M., Cruden, J., Diver, L. A., Findlay, C., Gardiner, S., Grattan, R., Lang, B., MacDonnell, J., McKnight, J., Morrison, C. A., Nairn, L., Slean, M. M., Stephen, E., Webb, A., Vincent, A., & Wilson, M.
- Affiliations
- Royal Hospital for Children (GB)
- Queen Elizabeth University Hospital (GB)
- Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK
- NHS Tayside (GB)
- Department of Paediatrics, Forth Valley Royal Hospital, Larbert, UK
- Wishaw General Hospital (GB)
- Victoria Hospital (GB)
- University Hospital Crosshouse (GB)
- Forth Valley Royal Hospital (GB)
- John Radcliffe Hospital (GB)
- Borders General Hospital (GB)
- Dumfries and Galloway Royal Infirmary (GB)
- Royal Alexandra Hospital (GB)
- University of Glasgow (GB)
- Royal Aberdeen Children's Hospital (GB)
- Raigmore Hospital (GB)
- Corresponding author
- Zuberi, Sameer M
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-07-13
- Volume
- 142
- Issue
- 8
- Pages
- 2303-2318
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC6658850
- OpenAlex
- W2961503558
- Cited by
- 459
- References
- 81
- Citations by year
- 2026: 49 · 2025: 82 · 2024: 87 · 2023: 67 · 2022: 76 · 2021: 44 · 2020: 48 · 2019: 6
- FWCI
- 34.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, cc-by-nc)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Epilepsy Research UK
- Dravet Syndrome UK
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- childhood-onset epilepsy, genetic epilepsy, incidence, phenotypic spectrum, PRRT2, SCN1A, KCNQ2, KCNQ3, KCNA2, KCNA1, Kv1.3 potassium channel, Kv1.5, KC
- MeSH terms
- Child, Preschool, Epilepsy, Female, Humans, Infant, Infant, Newborn, Male, Phenotype, Prospective Studies, Scotland, Cohort Studies, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.